The India hospital hand sanitizers market was valued at INR 3776.16 Crore in 2025, driven by the rising hospital-acquired infection rates and stringent hygiene protocols across the region. The market is anticipated to grow at a CAGR of 4.60% during the forecast period of 2026-2035, with the values likely to reach INR 5920.62 Crore by 2035.
Base Year
Historical Period
Forecast Period
UV-free, light-based hand sanitizers may accelerate hospital adoption due to safety, sustainability, and clinical efficacy improvements.
The market growth is driven by adoption of natural, herbal-based sanitizers, driven by demand for skin-safe, antibacterial infection control.
The demand is growing due to the rising incidence of hospital acquired infections in Indian ICUs, that will likely prioritize high-efficacy sanitizer procurement and compliance.
Compound Annual Growth Rate
4.6%
Value in INR Crore
2026-2035
*this image is indicative*
The market comprises hospital-grade sanitizing solutions designed to reduce hospital-acquired infections (HAIs) and improve patient safety. In India, approximately 10% of hospitalized patients experience HAIs. A 2023 study in a tertiary care ICU reported that 31.7% of patients developed HAIs, with an incidence density of 69.17 per 1,000 ICU-days, substantially increasing mortality risk and prolonging hospital stays. These rates are notably higher than in high-income countries, underscoring the urgent need for stringent infection control. Alcohol-based sanitizers serve as a frontline defence, aligning with public health goals to minimize infections, reduce healthcare costs, and elevate hygiene standards across India's healthcare infrastructure. The market is anticipated to grow at a CAGR of 4.60% during the forecast period of 2026-2035.
Innovations in Formulation to Elevate Clinical Value in Sanitizers
Technological advancement and regulatory need for safer skin-friendly solutions are driving ingredient innovations. For instance, in June 2025, some researchers at Parul University were awarded an Indian patent for a novel herbal organic hand sanitizer, leveraging cinchona and aloe vera extracts to effectively kill bacteria like E. coli and Staphylococcus aureus. Such developments are poised to boost sanitizer adoption in hospitals, offering gentler alternatives for healthcare worker and patient use, enhancing compliance, diversifying product offerings, and strengthening market competitiveness in the forecast period.
The market trends include the advent of innovative formulations in sanitizers and preference of plant based products.
UV-Activated Sanitization Innovation Enhances Safety and Efficiency
Increased demand for non-chemical disinfection and reduced environmental impact are fueling tech-based sanitizer innovation. For instance, in January 2023, Synpro Cleanova introduced India’s first visible-light-activated, UV-free hand sanitizer using photocatalytic technology, claiming 99.9% efficacy against coronaviruses while being harmless to humans. The development offers hospitals an eco-friendly, non-toxic option for frequent use, potentially reducing chemical exposure for staff and patients and improving hygiene compliance in healthcare settings during the forecast period.
Adoption of Plant-Based Sanitizers to India Hospital Hand Sanitizers Market Demand
Rising awareness around chemical exposure and preference for sustainable ingredients are boosting plant-based sanitizer adoption. For instance, in March 2021, Medimix launched a 100% natural antibacterial hand sanitizer gel made with neem, tulsi, and aloe vera extracts sourced from traditional botanical formulations. This product meets clinical hygiene standards while offering skin-friendly benefits, appealing to hospital staff and patient populations, a trend likely to expand product portfolios in institutional procurement through the forecast period.
Alcohol Based Segment to Hold a Significant Market Value for Segmentation by Type
The alcohol-based segment is expected to lead due to its proven effectiveness against a wide range of pathogens, including enveloped viruses like SARS-CoV-2. The World Health Organization recommends alcohol concentrations between 60-95% for clinical settings. A 2023 study in a tertiary care ICU in India found that 31.7% of patients developed hospital-acquired infections, with an incidence density of 69.17 per 1,000 ICU-days. These findings underscore the urgent need for reliable hand hygiene solutions, strengthening the market demand for alcohol-based sanitizers across Indian hospitals.
India’s North region is expected to lead due to its concentration of tertiary care hospitals, established pharmaceutical production facilities, and strong regulatory oversight in states like Delhi and Punjab. These areas adopted stringent Infection Prevention and Control (IPC) policies early, accelerating sanitizer procurement. The West region (Maharashtra, Gujarat) follows, driven by high hospital investment and industrial hygiene standards. In contrast, South and East regions exhibit growing uptake, while revenue remains concentrated in North and West due to procurement scale and regulatory compliance.
The key features of the market report comprise strategic initiatives by the leading players. The major companies in the market are as follows:
Headquartered in Norderstedt, Germany, and established in 1889, Schülke & Mayr is a pioneer in medical hygiene solutions. It launched its mikrozid® universal wipes green line in November 2023, high-performance, alcohol-based disinfecting wipes targeting healthcare facilities, approved for effective virus and bacterial elimination. These wipes support hospital hand hygiene protocols alongside sanitizer use. With a strong presence in India through distribution partnerships, Schülke provides regulated, high-efficacy products for critical clinical environments.
Founded in June 1991 and based in Mumbai, Eclat Pharma manufactures healthcare and personal-care products including hospital-grade hand sanitizer gels, antiseptic liquids, and disinfectant sprays. Its range serves institutional buyers like hospitals, clinics, and nursing facilities, with a noted 30% revenue increase in FY2023, signifying strong demand for its sanitization portfolio. By supporting bulk sanitizer supply and antiseptic hygiene products, Eclat strengthens infection control infrastructure in Indian hospitals.
Headquartered in Slough, United Kingdom, and established in 1823, Reckitt Benckiser is a prominent consumer health and hygiene company with a significant presence in India. Through its trusted brand Dettol, the company delivers a range of hand sanitizers tailored for hospital and institutional use. These include alcohol-based gel and liquid sanitizers formulated to meet healthcare-grade hygiene requirements. Reckitt’s longstanding market presence and recognized product quality make it a preferred choice for hospitals, supporting infection prevention initiatives and upholding safety protocols in clinical and surgical departments.
Procter & Gamble (P&G), established in 1837 and headquartered in Cincinnati, Ohio, operates extensively in India through its local subsidiaries. The company markets hygiene-focused solutions including hand sanitizers under its Safeguard brand. Designed for hospital and professional use, these sanitizers feature formulations that align with recommended clinical hygiene standards. P&G’s products are used across various healthcare touchpoints such as ICUs, general wards, and outpatient areas. Its focus on reliability and user safety has positioned the company as a consistent supplier in the hospital hygiene and infection control segment in India.
*Please note that this is only a partial list; the complete list of key players is available in the full report. Additionally, the list of key players can be customized to better suit your needs.*
Other players in the market include The Himalaya Drug Company, Unilever, Vi-Jon, Biocruz Pharmaceuticals (P.) Limited, Arbro Pharmaceuticals Pvt. Ltd., and Saphnix Life Sciences.
"India Hospital Hand Sanitizers Market Report and Forecast 2026-2035” offers a detailed analysis of the market based on the following segments:
Market Breakup by Form
Market Breakup by Type
Market Breakup by Distribution Channel
Market Breakup by Region
Upto 15% Off
USD
$1999 $1799
$3099 $2789
$4599 $3909
$5999 $5099
*While we strive to always give you current and accurate information, the numbers depicted on the website are indicative and may differ from the actual numbers in the main report. At Expert Market Research, we aim to bring you the latest insights and trends in the market. Using our analyses and forecasts, stakeholders can understand the market dynamics, navigate challenges, and capitalize on opportunities to make data-driven strategic decisions.*
Get in touch with us for a customized solution tailored to your unique requirements and save upto 35%!
Explore our key highlights of the report and gain a concise overview of key findings, trends, and actionable insights that will empower your strategic decisions.
| REPORT FEATURES | DETAILS |
| Base Year | 2025 |
| Historical Period | 2019-2025 |
| Forecast Period | 2026-2035 |
| Scope of the Report |
Historical and Forecast Trends, Industry Drivers and Constraints, Historical and Forecast Market Analysis by Segment:
|
| Breakup by Form |
|
| Breakup by Type |
|
| Breakup by Distribution Channel |
|
| Breakup by Region |
|
| Market Dynamics |
|
| Supplier Landscape |
|
| Companies Covered |
|
Datasheet
One User
USD 1,999
USD 1,799
tax inclusive*
Single User License
One User
USD 3,099
USD 2,789
tax inclusive*
Five User License
Five User
USD 4,599
USD 3,909
tax inclusive*
Corporate License
Unlimited Users
USD 5,999
USD 5,099
tax inclusive*
*Please note that the prices mentioned below are starting prices for each bundle type. Kindly contact our team for further details.*
Flash Bundle
Small Business Bundle
Growth Bundle
Enterprise Bundle
*Please note that the prices mentioned below are starting prices for each bundle type. Kindly contact our team for further details.*
Flash Bundle
Number of Reports: 3
20%
tax inclusive*
Small Business Bundle
Number of Reports: 5
25%
tax inclusive*
Growth Bundle
Number of Reports: 8
30%
tax inclusive*
Enterprise Bundle
Number of Reports: 10
35%
tax inclusive*
How To Order
Select License Type
Choose the right license for your needs and access rights.
Click on ‘Buy Now’
Add the report to your cart with one click and proceed to register.
Select Mode of Payment
Choose a payment option for a secure checkout. You will be redirected accordingly.
Gain insights to stay ahead and seize opportunities.
Get insights & trends for a competitive edge.
Track prices with detailed trend reports.
Analyse trade data for supply chain insights.
Leverage cost reports for smart savings
Enhance supply chain with partnerships.
Connect For More Information
Our expert team of analysts will offer full support and resolve any queries regarding the report, before and after the purchase.
Our expert team of analysts will offer full support and resolve any queries regarding the report, before and after the purchase.
We employ meticulous research methods, blending advanced analytics and expert insights to deliver accurate, actionable industry intelligence, staying ahead of competitors.
Our skilled analysts offer unparalleled competitive advantage with detailed insights on current and emerging markets, ensuring your strategic edge.
We offer an in-depth yet simplified presentation of industry insights and analysis to meet your specific requirements effectively.
Share